Device and drug firm Maelor gets cash injection
This article was originally published in Clinica
Executive Summary
Maelor of Wrexham, UK, has just announced a fully underwritten placing and open offer that will net it £2.9m ($4.75m), and enable it to press ahead with product development, expanding sales and acquiring other revenue generators. The offering comes at a crucial moment: the company predicts that without the fresh funds it would be down to its last $100,000 by the end of March.